The Mission of BioMune is to extend and improve the quality of life through the development of innovative therapeutic products that stimulate the immune system to cure chronic diseases and simultaneously reduce the cost of medical treatment. We will accomplish this Mission through internal research and collaborative ventures with other innovative life sciences development companies that will expand the advancement, application and licensing of our products.
Our therapeutics are based on natural proteins or small bio-organic molecules. We plan to isolate and sell these natural molecules as nutraceutical formulations, as well as optimize these compounds for pharmaceutical development.
Unlike many anti-cancer drugs that inhibit the growth and development of all cells including tumor cells (causing many undesirable side effects), our compounds activate the immune system or reactivate immune cells inhibited by cancers.
Our primary nutraceutical, MacrImmune, is a mixture of a plant protein and a plant bio-organic molecule that together shrank melanomas, sarcomas, and lymphomas in a few weeks, resulting in an over 90% cure rate, when administered orally (not injected) to mice.